Analyze Diet
Frontiers in veterinary science2021; 8; 629627; doi: 10.3389/fvets.2021.629627

Meropenem Administered via Intravenous Regional Limb Perfusion for Orthopedic Sepsis in Horses: A Clinical Retrospective Study.

Abstract: Septic synovitis is a critical orthopedic condition in horses. Early intervention is key, with antibiotic therapy typically initiated prior to culture and susceptibility reports becoming available. The pharmacokinetics of several antibiotics have been studied in horses for use in intravenous regional limb perfusion (IVRLP) for septic synovitis, including the carbapenem antibiotic, meropenem. For a variety of factors, some veterinary clinicians may select IVRLP meropenem as therapy for these cases. Meropenem is a vital antibiotic in human medicine, making veterinary use divisive. However, verifying the efficacy of meropenem contrasted to other IVRLP antibiotics is essential for appropriate antimicrobial stewardship. To investigate this, equine patient medical records at a single veterinary teaching hospital were examined. Cases treated with meropenem or gentamicin via IVRLP for septic synovitis were retrospectively analyzed for demographics, diagnostics, treatments, outcomes, and adverse effects. Twenty-three meropenem and 37 gentamicin treated horses were analyzed; demographic information was similar between groups. In the meropenem group, nine horses received meropenem only; the remainder received another antibiotic initially then changed to meropenem. Structures infected included joints (meropenem = 13, gentamicin = 17), tendon sheaths (meropenem = 5, gentamicin = 8) and navicular bursae (meropenem = 2, gentamicin = 6). Overall survival to discharge was 86% (52/60), with meropenem 91% (21/23) and gentamicin 84% (31/37), with no statistically significant differences noted between meropenem or gentamicin groups for overall survival to discharge or outcome after discharge. Twenty-four of 26 bacterial isolates obtained from culture were reported as sensitive to imipenem, a carbapenem antibiotic similar to meropenem. Reported susceptibility to other antibiotics such as ceftiofur ( = 22/26), ampicillin ( = 18/26), amikacin ( = 15/26), or gentamicin ( = 12/26) was also frequently present. In the population of this study, antimicrobial activity augmented with IVRLP using either meropenem or gentamicin both appear to be an effective treatment for septic synovial structures, therefore, less critical antimicrobials may be a viable and more judicious treatment option.
Publication Date: 2021-03-26 PubMed ID: 33842571PubMed Central: PMC8033006DOI: 10.3389/fvets.2021.629627Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research is a retrospective analysis of cases where horses with septic synovitis, a serious orthopedic condition, were treated using either meropenem or gentamicin antibiotics through intravenous regional limb perfusion (IVRLP). The study found that both antibiotics were effective treatments and did not significantly differ in survival outcomes.

Understanding the Research

  • The research focused on a condition called ‘septic synovitis’ which is a serious orthopedic condition often seen in horses. It is usually approached with early, preemptive antibiotic therapy before actual culture and susceptibility reports are obtained.
  • This study particularly examined the use of intravenous regional limb perfusion (IVRLP) method for administering antibiotics in horses. The antibiotics scrutinized in this study were meropenem and gentamicin.
  • Meropenem is a crucial antibiotic in human medicine; hence, its veterinary use is a subject of contention. Since meropenem is a carbapenem antibiotic, the study also considered the sensitivity of various bacterial strains to imipenem, another carbapenem antibiotic.

Execution of the Research

  • For conducting the research, patient records from a single veterinary teaching hospital were studied retrospectively. This involved chiefly examining cases where the horses were treated with either meropenem or gentamicin via IVRLP for septic synovitis.
  • The data was analyzed for different demographics, diagnostics, treatment methods used, outcomes achieved, and any adverse effects observed.
  • The research covered those cases where the horses had infections in joints, tendon sheaths and navicular bursae and had been treated with meropenem or gentamicin.

Findings of the Research

  • There were 23 cases where horses were treated with meropenem and 37 cases where gentamicin was administered; with nine horses in the meropenem group receiving only this antibiotic while the rest were first treated with a different antibiotic before switching to meropenem.
  • The research did not observe any statistically significant differences between the two groups in terms of overall survival to discharge or outcome post-discharge.
  • Out of 26 bacterial isolates obtained from culture, 24 were reported to be sensitive to imipenem, indicating the potential effectiveness of meropenem. Further, sensitivity was also observed to other antibiotics like ceftiofur, ampicillin, amikacin, or gentamicin.
  • The study concluded that IVRLP using either meropenem or gentamicin appears to be an effective treatment for septic synovial structures in horses. This suggests that less critical antibiotics might be used as a viable and more judicious treatment alternative.

Cite This Article

APA
Mosichuk AP, Smith JS, Tatarniuk DM, Troy JR, Kreuder AJ. (2021). Meropenem Administered via Intravenous Regional Limb Perfusion for Orthopedic Sepsis in Horses: A Clinical Retrospective Study. Front Vet Sci, 8, 629627. https://doi.org/10.3389/fvets.2021.629627

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 8
Pages: 629627
PII: 629627

Researcher Affiliations

Mosichuk, Allison P
  • College of Veterinary Medicine, Iowa State University, Ames, IA, United States.
Smith, Joseph S
  • Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, United States.
  • Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, United States.
Tatarniuk, Dane M
  • Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, United States.
Troy, Jarrod R
  • Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, United States.
Kreuder, Amanda J
  • Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, United States.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 35 references
  1. Kawano S, Matsumoto K, Hara R, Kuroda Y, Ikawa K, Morikawa N, Horino T, Hori S, Kizu J. Pharmacokinetics and dosing estimation of meropenem in Japanese patients receiving continuous venovenous hemodialysis.. J Infect Chemother 2015 Jun;21(6):476-8.
    doi: 10.1016/j.jiac.2015.02.011pubmed: 25869915google scholar: lookup
  2. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future.. Antimicrob Agents Chemother 2011 Nov;55(11):4943-60.
    doi: 10.1128/AAC.00296-11pmc: PMC3195018pubmed: 21859938google scholar: lookup
  3. Bidgood T, Papich MG. Plasma pharmacokinetics and tissue fluid concentrations of meropenem after intravenous and subcutaneous administration in dogs.. Am J Vet Res 2002 Dec;63(12):1622-8.
    doi: 10.2460/ajvr.2002.63.1622pubmed: 12492274google scholar: lookup
  4. Smith JS, Borts DJ, Slagel CC, Rajewski SM, Bousquet-Melou A, Ferran AA, Plummer PJ, Mochel JP. Pharmacokinetics of Ertapenem in Sheep (Ovis aries) with Experimentally Induced Urinary Tract Infection.. Comp Med 2019 Oct 1;69(5):413-418.
    doi: 10.30802/AALAS-CM-18-000144pmc: PMC6807722pubmed: 31581974google scholar: lookup
  5. Critically Important Antimicrobials for Human Medicine. 6 ed. WHO: Netherlands; (2018).
  6. Scott HM, Acuff G, Bergeron G, Bourassa MW, Gill J, Graham DW, Kahn LH, Morley PS, Salois MJ, Simjee S, Singer RS, Smith TC, Storrs C, Wittum TE. Critically important antibiotics: criteria and approaches for measuring and reducing their use in food animal agriculture.. Ann N Y Acad Sci 2019 Apr;1441(1):8-16.
    doi: 10.1111/nyas.14058pmc: PMC6850619pubmed: 30924540google scholar: lookup
  7. Gibson KT, McIlwraith CW, Turner AS, Stashak TS, Aanes WA, Trotter GW. Open joint injuries in horses: 58 cases (1980-1986).. J Am Vet Med Assoc 1989 Feb 1;194(3):398-404.
    pubmed: 2917911
  8. Gilbertie JM, Schnabel LV, Stefanovski D, Kelly DJ, Jacob ME, Schaer TP. Gram-negative multi-drug resistant bacteria influence survival to discharge for horses with septic synovial structures: 206 Cases (2010-2015).. Vet Microbiol 2018 Nov;226:64-73.
    doi: 10.1016/j.vetmic.2018.10.009pubmed: 30389045google scholar: lookup
  9. Palmer S, Hogan P. How to perform regional limb perfusion in the standing horse.. Proc Am Assoc Equine Pract (1999) 45:124–7.
    pubmed: 0
  10. Rubio-Martínez LM, Cruz AM. Antimicrobial regional limb perfusion in horses.. J Am Vet Med Assoc 2006 Mar 1;228(5):706-12, 655.
    doi: 10.2460/javma.228.5.706pubmed: 16506931google scholar: lookup
  11. Dahan R, Oreff GL, Tatz AJ, Raz T, Britzi M, Kelmer G. Pharmacokinetics of regional limb perfusion using a combination of amikacin and penicillin in standing horses.. Can Vet J 2019 Mar;60(3):294-299.
    pmc: PMC6380264pubmed: 30872853
  12. Hyde RM, Lynch TM, Clark CK, Slone DE, Hughes FE. The influence of perfusate volume on antimicrobial concentration in synovial fluid following intravenous regional limb perfusion in the standing horse.. Can Vet J 2013 Apr;54(4):363-7.
    pmc: PMC3595939pubmed: 24082163
  13. Rubio-Martínez LM, López-Sanromán J, Cruz AM, Santos M, Andrés MS, Román FS. Evaluation of safety and pharmacokinetics of vancomycin after intravenous regional limb perfusion in horses.. Am J Vet Res 2005 Dec;66(12):2107-13.
    doi: 10.2460/ajvr.2005.66.2107pubmed: 16379655google scholar: lookup
  14. Parra-Sanchez A, Lugo J, Boothe DM, Gaughan EM, Hanson RR, Duran S, Belknap JK. Pharmacokinetics and pharmacodynamics of enrofloxacin and a low dose of amikacin administered via regional intravenous limb perfusion in standing horses.. Am J Vet Res 2006 Oct;67(10):1687-95.
    doi: 10.2460/ajvr.67.10.1687pubmed: 17014317google scholar: lookup
  15. Kelmer G, Tatz AJ, Famini S, Bdolah-Abram T, Soback S, Britzi M. Evaluation of regional limb perfusion with chloramphenicol using the saphenous or cephalic vein in standing horses.. J Vet Pharmacol Ther 2015 Feb;38(1):35-40.
    doi: 10.1111/jvp.12140pubmed: 25073920google scholar: lookup
  16. Kelmer G, Tatz AJ, Kdoshim E, Britzi M, Segev G. Evaluation of the pharmacokinetics of imipenem following regional limb perfusion using the saphenous and the cephalic veins in standing horses.. Res Vet Sci 2017 Oct;114:64-68.
    doi: 10.1016/j.rvsc.2017.02.020pubmed: 28319829google scholar: lookup
  17. Nieto JE, Trela J, Stanley SD, Yamout S, Snyder JR. Pharmacokinetics of a combination of amikacin sulfate and penicillin G sodium for intravenous regional limb perfusion in adult horses.. Can J Vet Res 2016 Jul;80(3):230-5.
    pmc: PMC4924558pubmed: 27408337
  18. Cox KS, Nelson BB, Wittenburg L, Gold JR. Plasma, subcutaneous tissue and bone concentrations of ceftiofur sodium after regional limb perfusion in horses.. Equine Vet J 2017 May;49(3):341-344.
    doi: 10.1111/evj.12614pubmed: 27458113google scholar: lookup
  19. Fontenot RL, Langston VC, Zimmerman JA, Wills RW, Sloan PB, Mochal-King CA. Meropenem synovial fluid concentrations after intravenous regional limb perfusion in standing horses.. Vet Surg 2018 Aug;47(6):852-860.
    doi: 10.1111/vsu.12940pubmed: 30066453google scholar: lookup
  20. Motta RG, Martins LSA, Motta IG, Guerra ST, Paula CLd, Bolanos CAD. Multidrug resistant bacteria isolated from septic arthritis in horses.. Pesquisa Veterinária Brasileira (2017) 37:325–30.
  21. Schneider RK, Bramlage LR, Moore RM, Mecklenburg LM, Kohn CW, Gabel AA. A retrospective study of 192 horses affected with septic arthritis/tenosynovitis.. Equine Vet J 1992 Nov;24(6):436-42.
  22. Ludwig EK, van Harreveld PD. Equine Wounds over Synovial Structures.. Vet Clin North Am Equine Pract 2018 Dec;34(3):575-590.
    doi: 10.1016/j.cveq.2018.07.002pubmed: 30447770google scholar: lookup
  23. Langston VC, Fontenot RL, Byers JA, Andrews CM, Mochal-King CA. Plasma and synovial fluid pharmacokinetics of a single intravenous dose of meropenem in adult horses.. J Vet Pharmacol Ther 2019 Sep;42(5):525-529.
    doi: 10.1111/jvp.12770pubmed: 31222751google scholar: lookup
  24. Wiseman LR, Wagstaff AJ, Brogden RN, Bryson HM. Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.. Drugs 1995 Jul;50(1):73-101.
  25. Knafo SE, Graham JE, Barton BA. Intravenous and intraosseous regional limb perfusion of ceftiofur sodium in an avian model.. Am J Vet Res 2019 Jun;80(6):539-546.
    doi: 10.2460/ajvr.80.6.539pubmed: 31140842google scholar: lookup
  26. Dutton CJ, Delnatte PG, Hollamby SR, Crawshaw GJ. SUCCESSFUL TREATMENT OF DIGITAL OSTEITIS BY INTRAVENOUS REGIONAL PERFUSION OF CEFTIOFUR IN AN AFRICAN ELEPHANT (LOXODONTA AFRICANA).. J Zoo Wildl Med 2017 Jun;48(2):554-558.
    pubmed: 28749306doi: 10.1638/2015-0292r1.1google scholar: lookup
  27. Agarwal P, Agrawal PK, Sharma D, Baghel KD. Intravenous infusion for the treatment of diabetic and ischaemic non-healing pedal ulcers.. J Eur Acad Dermatol Venereol 2005 Mar;19(2):158-62.
  28. Miagkoff L, Archambault M, Bonilla AG. Antimicrobial susceptibility patterns of bacterial isolates cultured from synovial fluid samples from horses with suspected septic synovitis: 108 cases (2008-2017).. J Am Vet Med Assoc 2020 Apr 1;256(7):800-807.
    doi: 10.2460/javma.256.7.800pubmed: 32176585google scholar: lookup
  29. Getman LM, Sutter WW, Bertone AL. Infections of muscle, joint, and bone.. Equine Infectious Diseases 2nd ed. WB Saunders; 2014. p. 60–70.
  30. Zhanel GG, Simor AE, Vercaigne L, Mandell L. Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects.. Can J Infect Dis 1998 Jul;9(4):215-28.
    doi: 10.1155/1998/831425pmc: PMC3250889pubmed: 22346545google scholar: lookup
  31. CLSI . Understanding Susceptibility Test Data as a Component of Antimicrobial Stewardship in Veterinary Settings. Wayne, PA: CLSI; 2019.
  32. Colbath AC, Wittenburg LA, Gold JR, McIlwraith CW, Moorman VJ. The Effects of Mepivacaine Hydrochloride on Antimicrobial Activity and Mechanical Nociceptive Threshold During Amikacin Sulfate Regional Limb Perfusion in the Horse.. Vet Surg 2016 Aug;45(6):798-803.
    doi: 10.1111/vsu.12515pubmed: 27416788google scholar: lookup
  33. Davis JL. Update on Antimicrobial Drugs in Horses.. St. Louis, MO: W.B. Saunders. (2014).
  34. Lee YC, Huang YJ, Hung MC, Hung SC, Hsiao CY, Cho HL, Lai LF, Tong SH, Wang JT. Risk factors associated with the development of seizures among adult patients treated with ertapenem: A matched case-control study.. PLoS One 2017;12(7):e0182046.
  35. Fiorello CV, Beagley J, Citino SB. Antibiotic intravenous regional perfusion for successful resolution of distal limb infections: two cases.. J Zoo Wildl Med 2008 Sep;39(3):438-44.
    doi: 10.1638/2007-0177.1pubmed: 18817008google scholar: lookup

Citations

This article has been cited 0 times.